As a scientific leader whose work in the cystinosis field has been invaluable to the patient community, I wanted to reach out to you with this news and share additional context about what this means for you.
Horizon Pharma is a global pharmaceutical company that markets 11 medicines for rare diseases, pain and inflammation. Horizon Pharma’s orphan disease business is growing, and like Raptor, the company is committed to helping people with rare diseases live better lives.
Raptor employees joined Horizon Pharma, and together we all will continue our dedicated work to support your needs.
Horizon Pharma is actively engaged with all of Raptor’s clinical, distribution and commercial partners to ensure a smooth transition and minimize disruption to patient access and support services. We do not anticipate any near-term changes in how we interact with you, and your company contacts remain the same.
Horizon Pharma firmly believes that when patients benefit, everyone benefits. The company has a long-term commitment to rare diseases and will continue to support your goal of improving patients’ day-to-day well-being by providing accurate and timely information, and the medicines you depend on.